INNOVATIVE EYEWEAR, INC. Increase (Decrease) in Accounts Receivable
INNOVATIVE EYEWEAR, INC. (LUCY) reported Increase (Decrease) in Accounts Receivable of $2.44 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $73.08K.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$70.65K.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $63.16K, a 50.39% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $21.29K, a 65.56% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for fiscal 2025 was $36.78K, a 705.45% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for fiscal 2024 was $4.57K, a 24.14% increase from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for fiscal 2023 was $3.68K, a 97.99% decline from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. increase (decrease) in accounts receivable for fiscal 2022 was $183.09K, a 321.93% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $73.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.44K 10-Q · filed 2026-08-14 | $65.59K derived: sum of 3 quarters · filed 2026-08-14 | $86.88K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$70.65K 10-Q · filed 2026-05-14 | -$7.49K derived: sum of 2 quarters · filed 2026-05-14 | $13.80K derived: sum of 3 quarters · filed 2026-05-14 | -$11.49K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $63.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $84.44K derived: sum of 2 quarters · filed 2026-03-25 | $59.15K derived: sum of 3 quarters · filed 2026-08-14 | $36.78K 10-K · filed 2026-03-25 |
| 2025-09-30 | $21.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$4.01K derived: sum of 2 quarters · filed 2026-08-14 | -$26.38K 10-Q · filed 2025-11-13 | $15.61K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$25.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$47.67K 10-Q · filed 2026-08-14 | -$5.67K derived: sum of 3 quarters · filed 2026-08-14 | $7.18K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$22.37K 10-Q · filed 2026-05-14 | $19.62K derived: sum of 2 quarters · filed 2026-05-14 | $32.48K derived: sum of 3 quarters · filed 2026-05-14 | $35.02K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $41.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $54.85K derived: sum of 2 quarters · filed 2026-03-25 | $57.39K derived: sum of 3 quarters · filed 2026-03-25 | $4.57K 10-K · filed 2026-03-25 |
| 2024-09-30 | $12.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $15.39K derived: sum of 2 quarters · filed 2025-11-13 | -$37.43K 10-Q · filed 2025-11-13 | -$25.99K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$50.28K 10-Q · filed 2025-08-14 | -$38.85K derived: sum of 3 quarters · filed 2025-08-14 | -$72.82K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$52.82K 10-Q · filed 2025-05-13 | -$41.38K derived: sum of 2 quarters · filed 2025-05-13 | -$75.36K derived: sum of 3 quarters · filed 2025-05-13 | -$66.67K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $11.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$22.53K derived: sum of 2 quarters · filed 2025-03-24 | -$13.85K derived: sum of 3 quarters · filed 2025-03-24 | $3.68K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$33.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$25.29K derived: sum of 2 quarters · filed 2024-11-12 | -$7.76K 10-Q · filed 2024-11-12 | $31.14K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $8.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $26.21K 10-Q · filed 2024-08-12 | $65.11K derived: sum of 3 quarters · filed 2024-08-12 | $65.82K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $17.53K 10-Q · filed 2024-05-14 | $56.42K derived: sum of 2 quarters · filed 2024-05-14 | $57.13K derived: sum of 3 quarters · filed 2024-05-14 | $90.29K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $38.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $39.61K derived: sum of 2 quarters · filed 2024-03-25 | $72.77K derived: sum of 3 quarters · filed 2024-03-25 | $183.09K 10-K · filed 2024-03-25 |
| 2022-09-30 | $711.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $33.87K derived: sum of 2 quarters · filed 2023-11-14 | $144.20K 10-Q · filed 2023-11-14 | $160.52K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $33.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $143.49K 10-Q · filed 2023-08-11 | $159.81K derived: sum of 3 quarters · filed 2023-08-11 | $177.37K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $110.33K 10-Q · filed 2023-05-12 | $126.65K derived: sum of 2 quarters · filed 2023-05-12 | $144.21K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $16.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $33.88K derived: sum of 2 quarters · filed 2023-03-24 | $43.39K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $17.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $27.07K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $9.51K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |